Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial.
J Allergy Clin Immunol
; 148(3): 783-789, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-33744327
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Anti-Asthmatic Agents
/
Janus Kinase Inhibitors
/
Nitric Oxide
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2021
Document type:
Article
Country of publication:
Estados Unidos